AMENDMENT NO. 3 TO LICENSE AND SUPPLY AGREEMENTLicense and Supply Agreement • August 10th, 2022 • Societal CDMO, Inc. • Pharmaceutical preparations
THIS AMENDMENT NO. 3 TO LICENSE AND SUPPLY AGREEMENT (this “Amendment No. 3”) is made as of July 1, 2022 by and between Societal CDMO Gainesville, LLC (f/k/a Recro Gainesville LLC) (as successor to Alkermes Pharma Ireland Limited) (“Societal”) and Lannett Company, Inc. (as successor to Kremers Urban Pharmaceuticals, Inc.) (“Lannett”).
